|
|
|
|
letter: infliximab is the conventional trick for ulcerative colitis as a novel therapeutic option against sars-cov-2 infection
|
|
|
|
|
|
|
|
نویسنده
|
keikha masoud
|
|
منبع
|
international journal of infection - 2020 - دوره : 7 - شماره : 4 - صفحه:1 -2
|
|
|
|
|
کلیدواژه
|
infliximab ,covid-19 ,sars-cov-2
|
|
آدرس
|
mashhad university of medical sciences, faculty of medicine, student research committee, department of microbiology and virology, iran
|
|
پست الکترونیکی
|
masoud.keykha90@gmail.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|